ATE87480T1 - 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe. - Google Patents

4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe.

Info

Publication number
ATE87480T1
ATE87480T1 AT89107099T AT89107099T ATE87480T1 AT E87480 T1 ATE87480 T1 AT E87480T1 AT 89107099 T AT89107099 T AT 89107099T AT 89107099 T AT89107099 T AT 89107099T AT E87480 T1 ATE87480 T1 AT E87480T1
Authority
AT
Austria
Prior art keywords
quinolinecarbone
immuno
derivatives useful
suppressive agents
useful
Prior art date
Application number
AT89107099T
Other languages
English (en)
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Application granted granted Critical
Publication of ATE87480T1 publication Critical patent/ATE87480T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT89107099T 1988-04-26 1989-04-20 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe. ATE87480T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
EP89107099A EP0339485B1 (de) 1988-04-26 1989-04-20 4-Chinolincarbon-Derivate, brauchbar als immuno-suppressive Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE87480T1 true ATE87480T1 (de) 1993-04-15

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89107099T ATE87480T1 (de) 1988-04-26 1989-04-20 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe.

Country Status (13)

Country Link
US (1) US4968701A (de)
EP (1) EP0339485B1 (de)
JP (1) JP2650757B2 (de)
KR (1) KR0134376B1 (de)
AT (1) ATE87480T1 (de)
CA (1) CA1333155C (de)
DE (1) DE68905642T2 (de)
DK (1) DK170414B1 (de)
IE (1) IE64760B1 (de)
IL (1) IL90055A (de)
MY (1) MY106038A (de)
PT (1) PT90363B (de)
ZA (1) ZA893087B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
EP0830133A1 (de) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutische zusammensetzung für arthritis
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
ES2173391T3 (es) * 1996-08-16 2002-10-16 Pfizer Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
DK2160950T3 (da) 2004-09-27 2015-06-08 Novozymes As Enzymgranuler
TN2016000197A1 (en) 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (de) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576445A5 (de) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Also Published As

Publication number Publication date
PT90363B (pt) 1994-08-31
KR900016137A (ko) 1990-11-12
DK200289A (da) 1989-10-27
PT90363A (pt) 1989-11-10
IE891328L (en) 1989-10-26
EP0339485B1 (de) 1993-03-31
IL90055A (en) 1993-05-13
ZA893087B (en) 1990-12-28
DE68905642D1 (de) 1993-05-06
DK200289D0 (da) 1989-04-25
CA1333155C (en) 1994-11-22
MY106038A (en) 1994-03-31
DK170414B1 (da) 1995-08-28
AU628045B2 (en) 1992-09-10
DE68905642T2 (de) 1993-08-12
KR0134376B1 (ko) 1998-04-21
AU3332189A (en) 1989-11-02
IL90055A0 (en) 1989-12-15
JPH01313428A (ja) 1989-12-18
IE64760B1 (en) 1995-09-06
JP2650757B2 (ja) 1997-09-03
US4968701A (en) 1990-11-06
EP0339485A1 (de) 1989-11-02

Similar Documents

Publication Publication Date Title
ATE87480T1 (de) 4-chinolincarbon-derivate, brauchbar als immuno- suppressive wirkstoffe.
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
SE7903186L (sv) Cerebralverksamt medel
DK653688D0 (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
NO179671C (no) Substituerte cykloheksanderivater, anvendelse av disse for fremstilling av legemidler samt legemiddel for behandling type II diabetes og andre sykdommer
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
ATE53376T1 (de) Entzuendungshemmende agentien.
MA22495A1 (fr) Derives d'amidinophenylalanine, procede pour leur preparation et leur utilisation
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
ATE107648T1 (de) 1-carbacephalosporin-antibiotika.
NZ223333A (en) 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
DE59206181D1 (de) (1'S)-Hydroxyalkyloxapenem-3-carbonsäuren und ihre Verwendung als Betalactamasehemmer
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
IT1183890B (it) Dispositivo di impianto per il trattamento chirurgico dell'infertilita da ostruzione tubarica
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari
FR2757858B1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.
FR2645445B1 (fr) Technique d'elimination du pyralene et de melanges pyralene-huiles par voie biologique
IT8983421A0 (it) Sistema di giunzione particolarmente idoneo per l'assemblaggio di tavoli.